SCHEMBL16356647

SCHEMBL16356647

c1ccc(N(c2ccccc2)c2ccc(N(c3ccccc3)c3ccc(-c4ccc(-n5c6ccccc6c6c7ccccc7c7ccccc7c65)cc4)cc3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ATM Q13315 1/20 0.40
HDAC4 P56524 1/20 0.34
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KMT2A Q03164 2/20 0.32
MAPK8 P45983 1/20 0.32
IL1R1 P14778 1/20 0.32
APP P05067 2/20 0.31
MEN1 O00255 1/20 0.31
HTT P42858 1/20 0.31
MAPK1 P28482 1/20 0.31
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16356633 1.00 L3MBTL1 (0.40) L3MBTL1KDM4EATMHDAC4ALDH1A1
SCHEMBL16356639 0.99 L3MBTL1 (0.39) L3MBTL1KDM4EATMHDAC4ALDH1A1
SCHEMBL16356634 0.99 L3MBTL1 (0.39) L3MBTL1KDM4EATMHDAC4ALDH1A1
SCHEMBL16356666 0.97 L3MBTL1 (0.40) L3MBTL1KDM4EATMHDAC4ALDH1A1
SCHEMBL20812930 0.97 L3MBTL1 (0.40) L3MBTL1KDM4EATMHDAC4ALDH1A1
SCHEMBL18668033 0.96 L3MBTL1 (0.43) L3MBTL1KDM4EATMALDH1A1MAPT
SCHEMBL17123081 0.94 L3MBTL1 (0.41) L3MBTL1KDM4EATMHDAC4ALDH1A1
SCHEMBL17445361 0.93 L3MBTL1 (0.42) L3MBTL1KDM4EATMHDAC4ALDH1A1
SCHEMBL17445374 0.93 L3MBTL1 (0.39) L3MBTL1KDM4EATMHDAC4ALDH1A1
SCHEMBL17123104 0.93 L3MBTL1 (0.44) L3MBTL1KDM4EATMHDAC4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10026905-B2 Compound, organic electric element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2018-07-17 US disclosed
US-10026905-B2 Compound, organic electric element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2018-07-17 US disclosed
US-20140374722-A1 COMPOUND, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2014-12-25 US disclosed
US-20140374722-A1 COMPOUND, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2014-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10026905-B2 Compound, organic electric element using the same, and an electronic device thereof ORAI2, TMEM109, EML4 L3MBTL1 749/4885KDM4E 1695/4885ATM 4083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.